MONROVIA, Calif., Nov. 29 /PRNewswire-FirstCall/ -- STAAR Surgical Company , a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will present at the BMO Capital Markets 2007 Focus on Healthcare Conference on Tuesday, December 4, 2007 at the Millennium Broadway Hotel in New York City. Barry G. Caldwell, STAAR Surgical’s Chief Executive Officer, will discuss the Company’s business strategy and historical financial performance at 2:00 p.m. Eastern Time.
Attendance at the conference is by invitation only. A live audio webcast of STAAR’s presentation may be accessed through the Company’s website at http://www.staar.com. An archived replay of the presentation will be available after the live presentation and can also be accessed at http://www.staar.com.
About STAAR Surgical
STAAR is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR’s products are used by ophthalmic surgeons and include the Visian ICL(TM), a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 40 countries. More than 85,000 ICLs have been sold worldwide. More information is available at http://www.staar.com.
CONTACT: investors, Douglas Sherk or Donald Takaya, +1-415-896-6820, or
media, Steve DiMattia, +1-646-201-5445, all of EVC Group, for STAAR
Surgical
Web site: http://www.staar.com/
